Drug-drug interactions in cardiothoracic intensive care unit of a pulmonary teaching hospital
Conclusions: Severity and drug combinations related to DDIs in the cardiothoracic ICU differ from other ICU settings. Knowledge of the epidemiology of drug interactions may help clinical practitioners to reduce the risk of adverse drug events.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Baniasadi, S., Bastani, M., Farzanegan, B. Tags: 1.13 Clinical Problems - Other Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Cipro | Ciprofloxacin | Combivent | Drugs & Pharmacology | Epidemiology | Fentanyl | Heart | Hospital Management | Intensive Care | Lung Cancer | Lung Transplant | Prograf | Respiratory Medicine | Restasis | Study | Tacrolimus | Teaching | Teaching Hospitals | Tracheal Cancer | Transplant Surgery | Transplants | Universities & Medical Training